MYDA Advisors
TLSIW icon

MYDA Advisors’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

MYDA Advisors’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-42,949
Closed -$11K – 241
2022
Q1 		$11K Sell
42,949
-76,851
-64% -$33K ﹤0.01% 204
2021
Q4 		$62K Hold
119,800
– – 0.02% 225
2021
Q3 		$98K Sell
119,800
-200
-0.2% -$186 0.03% 234
2021
Q2 		$122K Buy
120,000
+53,334
+80% +$52.6K 0.03% 252
2021
Q1 		$73K Buy
+66,666
New +$120K 0.02% 276

Other funds holding TLSIW

Mangrove Partners
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Angelo Gordon & Co
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Clear Street
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

MYDA Advisors's TLSIW Position: Q2 2022 in Review

MYDA Advisors sold out of TriSalus Life Sciences Warrant (TLSIW) in Q2 2022, closing a stake of 42,949 shares — an estimated $11K sold.

MYDA Advisors first reported a position in TLSIW in Q1 2021 and held it in 5 quarters. The position peaked at $122K in Q2 2021. 30 funds tracked by Wall St. Rank hold TLSIW as of Q2 2022.

  • MYDA Advisors reported no remaining TriSalus Life Sciences Warrant position as of Q2 2022 after selling out during the quarter.
  • MYDA Advisors sold 42,949 TriSalus Life Sciences Warrant shares in Q2 2022, an estimated $11K.
  • MYDA Advisors first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 5 quarters.
  • MYDA Advisors's TriSalus Life Sciences Warrant position peaked at $122K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2022.

Based on MYDA Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.